After Hours
$
11.48
Change
0.00 0.00%
Volume
Volume 100,470
Jun 28, 2022, 4:56 p.m.
Quotes are delayed by 20 min
Today's close
$ 11.70
$ 11.48
Change
-0.22 -1.88%
Day low
Day high
$11.22
$11.91

52 week low
52 week high
$6.43
$27.86

Market cap
$1.68B
Average volume
2.29M
P/E ratio
N/A
Rev. per Employee
$124,158
EPS
-2.20
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on ALLO
-
Allogene Therapeutics stock price target cut to $21 from $30 at B. Riley
- Tomi Kilgore
-
Beam Gets FDA Nod for First Gene-Editing Trial
- Barron's Online
-
Allogene Therapeutics stock price target cut to $30 from $40 at B. Riley
- Tomi Kilgore
-
Allogene Therapeutics downgraded to hold from buy at Stifel Nicolaus
- Tomi Kilgore
-
Cancer Biotechs Are on the Move in Advance of Big Conference
- Barron's Online
-
Allogene Therapeutics upgraded to buy from hold at Truist
- Tomi Kilgore
-
Biotech Is Down. How It Could Come Back.
- Barron's Online
-
Will Biotech Stocks' Slide Become a Rout? June Holds the Key.
- Barron's Online
-
Allogene Therapeutics started at buy with $52 stock price target at B. Riley
- Tomi Kilgore
-
Allogene Therapeutics upgraded to buy from hold at Stifel Nicolaus
- Tomi Kilgore
-
With Rare Speed, Gene Editing Emerges as Biotech’s New Cutting Edge
- Barron's Online
-
Race for Multiple Myeloma Drugs Not Moving Stocks — Yet
- Barron's Online
-
The Pandemic Speeds Up the Health-Care Revolution
- Barron's Online
-
4 Biotech Stocks That Are Seeing Big Buys in June
- Barron's Online
-
Allogene Therapeutics stock price target raised to $50 from $32 at SunTrust RH
- Tomi Kilgore
-
Allogene Therapeutics downgraded to market perform from outperform at Raymond James
- Tomi Kilgore
-
Allogene Therapeutics downgraded to hold from buy at SunTrust RH
- Tomi Kilgore
- Loading more headlines...
Other News on ALLO
-
Allogene Therapeutics: Multibagger Potential, But Terribly Risky
- Seeking Alpha
-
Allogene Therapeutics (ALLO) Investor Presentation (Slideshow)
- Seeking Alpha
-
Caribou Charges Ahead on Study Results
- GuruFocus.com
-
Allogene Therapeutics GAAP EPS of -$0.56 beats by $0.02
- Seeking Alpha
-
10-Q: ALLOGENE THERAPEUTICS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Notable earnings after Wednesday's close
- Seeking Alpha
-
Allogene Therapeutics opens new manufacturing site in California
- Seeking Alpha
-
Allogene: Leading The Allogeneic CAR-T Space, Again
- Seeking Alpha
- Loading more headlines...
Press Releases on ALLO
-
Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030
- Financial News Media
-
Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030
- PR Newswire - PRF
-
Allogene Flat on Study Results
- Baystreet.ca
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com